Hazards of dose escalation in prostate cancer radiotherapy.
about
Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer.Estimation of α/β for late rectal toxicity based on RTOG 94-06MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer.Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment.Dose-guided radiation therapy with megavoltage cone-beam CT.Particle therapy in prostate cancer: a review.Current role and future perspectives of magnetic resonance spectroscopy in radiation oncology for prostate cancer.Measurement of characteristic prompt gamma rays emitted from oxygen and carbon in tissue-equivalent samples during proton beam irradiation.Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions.From radiobiology to technology: what is changing in radiotherapy for prostate cancer.Megavoltage cone beam computed tomography: Commissioning and evaluation of patient dose.PMH 9907: Long-term outcomes of a randomized phase 3 study of short-term bicalutamide hormone therapy and dose-escalated external-beam radiation therapy for localized prostate cancer.Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic tracking.Feasibility study on effect and stability of adaptive radiotherapy on kilovoltage cone beam CTReal-time dosimetry in external beam radiation therapy.Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleeding.The quantitative Gleason score improves prostate cancer risk assessment.Rectal planning risk volume correlation with acute and late toxicity in 3-dimensional conformal radiation therapy for prostate cancer.Hypofractionated helical tomotherapy using 2.5-2.6 Gy daily fractions for localized prostate cancer.Early Experiences of Image Guided Prostate and Pelvic Nodal Irradiation With Intensity Modulated Radiation Treatment in Localized Prostate Cancer.Stereotactic body radiotherapy for prostate cancer: treatment approaches and clinical outcomes.Radiopaque marker motion during pre-treatment CBCT as a predictor of intra-fractional prostate movement.Concordance in the perception of couples recovering from primary surgical treatment of prostate cancer.Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy.Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?A comparison of daily megavoltage CT and ultrasound image guided radiation therapy for prostate cancer.[Radiotherapy for locally advanced prostate cancer].Decreasing the Dose to the Rectal Wall by Using a Rectal Retractor during Radiotherapy of Prostate Cancer: A Comparative Treatment Planning Study
P2860
Q34556112-46A7F91D-7909-490F-9B5A-FCBD5D807CF6Q35186584-423750CA-50D5-4C39-AD77-7AD405D983A0Q36321659-ACAB3469-E642-4E27-B972-41C1EB5B6965Q36364403-2F4D5CCA-03F4-4243-ACB3-451801AEA10FQ36596334-3B6B9F59-FB77-4FEA-94C1-EF129C34B2E5Q36847567-8091C429-90F1-4819-A5F9-12EA4868E2E2Q36866123-E8C0562B-63CC-490E-8134-A6C1DD52EFD8Q37237881-985E3F0D-35CB-413A-BA35-261ED8703A21Q37965553-44105F42-B37B-4192-9569-EFA3457C92F0Q38191990-1EE7A03E-E4DE-4467-891D-7CB91F663879Q40105263-FA16766B-D497-4E2B-9BBB-9B29E1443213Q40738452-A26D3A9E-66AD-400C-8B23-8C66579266CEQ41942147-00E41389-78EF-4398-9BFE-DED92526CE42Q42031996-D531BB21-5F32-4A5F-AA02-B6F9EB3752F7Q42118456-434A7E31-CAC7-4EA3-B318-516051DE0487Q42571229-C463BF6F-4679-4689-942C-AD8623C39BD1Q43637469-4FC41C2C-AF5F-4CF6-B48C-25CC1DA0EDE0Q44057423-C025883B-8168-43DF-BACA-F65E27534CB3Q44852521-5F1B1FDD-2C2C-4841-9374-934C154F2386Q45905246-B9EF73CC-C21F-413E-BCED-9E1ADD7BEF73Q47140723-CEE371D4-3818-4198-96E1-4EC55D73D7CEQ48746003-468D8AFC-8C30-4A1C-BB86-B8C13B44FBC9Q50742219-554A0C5E-26E3-40CA-BB8B-1DCE6F16D1D2Q51904524-3D33F16B-6D6A-480F-AAB3-0CCD50997A74Q52958760-85CB83CD-7E59-48E8-BF04-1543FB82A7CBQ53371667-967BE11F-2A95-4135-83CF-8C614ECEEE9FQ53393106-40D80F31-0FEE-4E80-A74F-C096D4893FBCQ59050740-DD1822C1-AB25-4B17-8D2A-7EF15CDB4E0A
P2860
Hazards of dose escalation in prostate cancer radiotherapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Hazards of dose escalation in prostate cancer radiotherapy.
@ast
Hazards of dose escalation in prostate cancer radiotherapy.
@en
type
label
Hazards of dose escalation in prostate cancer radiotherapy.
@ast
Hazards of dose escalation in prostate cancer radiotherapy.
@en
prefLabel
Hazards of dose escalation in prostate cancer radiotherapy.
@ast
Hazards of dose escalation in prostate cancer radiotherapy.
@en
P2093
P1476
Hazards of dose escalation in prostate cancer radiotherapy
@en
P2093
Alan Pollack
Deborah Kuban
Eugene Huang
George Starkschall
Isaac Rosen
Larry Levy
P304
P356
10.1016/S0360-3016(03)00772-7
P407
P50
P577
2003-12-01T00:00:00Z